Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited financials ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 to consider and approve the unaudited financial results for the quarter and half year ended 30 September 2025. The trading window for designated persons has been closed since 1 October 2025 and will remain closed until 16 November 2025, i.e., 48 hours after the results are declared. This is a routine regulatory filing under SEBI's Listing Regulations (Regulation 29) and does not contain any actual financial numbers or specific disclosures beyond the meeting agenda. No details on revenue, profit, margins, or any other financial metric are provided in this intimation.
No immediate impact on shareholders or stock price from this filing alone — it is a procedural notice. Investors should watch for the actual Q2/H1 FY26 results to be released on or after 14 November 2025 to assess the company's performance.